Vaccine Adjuvants

SPI Pharma has extensive experience and knowledge of aluminum hydroxide chemistry, with more than 70 years for antacid forms and more than 20 years for VAC gels as a vaccine adjuvant. The result of this expertise is products with a very regular profile in terms of compliance, morphology, particle size distribution, and protein adsorption capacity.

SPI has two facilities for the production of its VAC products, one in France and the other in the US. This allows us to ensure security of supply. Both sites produce under cGMP conditions and are regularly audited by the ANSM (French health agency), FDA, and many customers.